TY - THES A1 - Mutzberg, Lisa-Camilla T1 - Oral Enzyme Therapy in Systemic Analgetic Treatment N2 - The possibility of an oral enzyme combination being able to replace diclofenac in the treatment of pain and inflammation is discussed. Oral enzyme therapy involves the use of proteolytic enzymes like bromelain, serratiopeptidase, trypsin, rutin, and papain. The goal of oral enzyme therapy is to replace non-steroidal anti-inflammatory drugs (NSAIDs) in the treatment of symptoms requiring short or long-term treatment due to the side effects of NSAIDs for example diclofenac. The main analysis is focused on the analgesic and anti-inflammatory effects of oral enzyme therapy. The results are based on database retrieval covering single oral enzymes and oral enzyme combinations like Wobenzym and Phlogenzym. Osteoarthritis and post- surgery treatment studies of oral enzyme therapy are included to analyze the efficacy and effectiveness of the new treatment approach. Bromelain, serratiopeptidase, and rutin are covered in their industrial production. Safety and efficacy, trial diversity, economics, and the potential of oral enzymes being the new homeopathy are discussed. Oral enzymes show a great safety profile in the overall comparison to NSAIDs with tolerability rated as good and very good by patients and physicians. The trial diversity has an impact on the comparability resulting in the need for a cohesion set-up for the retrieval of evidence on the efficacy and effectiveness of oral enzyme therapy. The economic situation of oral enzymes is defined by the currently expensive production of enzymes with a possible reduction in retail price due to new techniques and technology. With the presence of new studies of high quality in the future, a detailed revision of facts is advised on oral enzymes being an alternative to NSAIDs. KW - Oral enzyme therapy KW - NSAIDs KW - Proteolytic enzymes KW - Diclofenac KW - Osteoarthritis Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:hbz:1383-opus4-15107 ER -